Atlas Trials

A Non-Blinded Study Demonstrating the Effectiveness and Safety of Azilect Alone or in Combination Therapy in Parkinson's Disease

Clinical trial NCT00399477 · COMPLETED

Trial details

NCT number
NCT00399477
Sponsor
Teva Neuroscience, Inc.
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Parkinson's Disease
Start date
2006-10-01
Primary completion
2007-07-01
Enrollment
200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.